From October 1, 2023 to December 31, 2023, the company has repurchased 957,000 shares, representing 0.21% for $26.15 million. With this, the company has completed the repurchase of 9,846,000 shares, representing 2.19% for $304.77 million under the buyback announced on March 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28 USD | -0.39% | -0.57% | -0.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.32% | 12.63B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.